Article Information
History
- June 21, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Zubeida Salaam-Dreyer1,
- Elizabeth M. Streicher2,
- Frederick A. Sirgel2,
- Fabrizio Menardo3,4,
- Sonia Borrell3,4,
- Miriam Reinhard3,4,
- Anna Doetsch3,4,
- Patrick G.T. Cudahy5,
- Erika Mohr-Holland6,
- Johnny Daniels6,
- Anzaan Dippenaar7,
- Mark P. Nicol8,
- Sebastien Gagneux3,4,
- Robin M. Warren2 and
- Helen Cox1,9,*
- 1Division of Medical Microbiology, Department of Pathology, University of Cape Town, South Africa
- 2DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa
- 3Swiss Tropical and Public Health Institute, Basel Switzerland
- 4University of Basel, Basel, Switzerland
- 5Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- 6Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa
- 7Tuberculosis Omics Research Consortium, Family Medicine and Population Health, Institute of Global Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
- 8Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, Australia
- 9Institute of Infectious Disease and Molecular Medicine and Wellcome centre for Infectious Disease Research, University of Cape Town, South Africa
- ↵* Corresponding author; email: helen.cox{at}uct.ac.za
Posted June 21, 2021.
Rifampicin mono-resistant tuberculosis is not the same as multidrug-resistant tuberculosis: a descriptive study from Khayelitsha, South Africa
